Featured Research

from universities, journals, and other organizations

Promising Therapies For Haemophilia & Heart Disease

Date:
August 11, 2005
Source:
Research Australia
Summary:
Professor Denisa Wagner and her Harvard colleagues have made ground-breaking discoveries that provide hope of an alternative treatment option for haemophilia sufferers.

Haemophilia is a hereditary blood disease, primarily affecting males,where the blood fails to clot causing potentially life-threatening'bleeds'. About one in 6000 Australian males is born with haemophiliain severe, moderate or mild form. People with haemophilia rely onintravenous infusion of recombinant Factor VIII clotting protein.

Professor Denisa Wagner and her Harvard colleagues have madeground-breaking discoveries that provide hope of an alternativetreatment option for haemophilia sufferers.

Presenting this research, at the XXth Congress of theInternational Society on Thrombosis & Haemostasis in Sydney today,Wagner said, "We have demonstrated that a protein called P-selectin isimportant for blood clotting and altering its levels in the bloodstreamby infusion appears to have great therapeutic potential."

Infusion of P-selectin could provide an affordable and moreeffective means of achieving clotting to stop bleeding incidents inhaemophiliacs. Because they carry it naturally in their bodies,patients are highly unlikely to make antibodies against P-selectin.P-selectin also has a longer half-life than clotting factors sotreatment is likely to be less frequent.

"This promises to be a much easier and more effective approach for sufferers, particularly children," said Wagner.

Wagner went on to report, "Blood clotting is an intricatelybalanced process. Blood clots in the heart or brain can result in aheart attack or stroke. Our studies in mouse models have shown thatinhibition of P-selectin reduces atherosclerosis (hardening of thearteries) and the work of our collaborators shows that the eventsleading to deep vein thrombosis are reduced. P-selectin inhibitors havealso been shown to be anti-thrombotic in early human trials"

Measurement of P-selectin levels in the blood stream mayprovide a new diagnostic tool to identify people at risk of heartdisease and stroke. Levels above baseline could alert clinicians topotentially fatal events. Several pharmaceutical companies are nowsearching for compounds that target P-selectin.

"This would represent a major breakthrough in diagnosing andtreating cardiovascular disease," she said. "There is still a greatdeal to be learned about this protein. This research could contributesignificantly to effective strategies to inhibit or enhance P-selectindepending on clinical need".


Story Source:

The above story is based on materials provided by Research Australia. Note: Materials may be edited for content and length.


Cite This Page:

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins